High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial

202344 citationsJournal Articlegold Open Access

Authors

Sandra D. Cassard · Johns Hopkins University

Kathryn C. Fitzgerald · Johns Hopkins University

Peiqing Qian · Swedish Medical Center

Susan A Emrich · Johns Hopkins University

Christina Azevedo · University of Southern California

Andrew Goodman · University of Rochester

Elizabeth A. Sugar

Abstract

This investigation was supported by a grant from the National Multiple Sclerosis Society (RG 4407A2/1). Teva Neuroscience, Inc. provided Copaxone (GA) for the duration of the trial.

Topics & Keywords

Multiple Sclerosis Research Studies Psoriasis: Treatment and Pathogenesis Fibromyalgia and Chronic Fatigue Syndrome Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: EClinicalMedicine

Volume 59, pp. 101957-101957

DOI: 10.1016/j.eclinm.2023.101957

Field-Weighted Citation Impact: 11.21